¡¦¥Ë¥å¡¼¥¹ ¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹¤Ë´¶À÷¤¹¤ë¤È¤³¤¦¤Ê¤ë ÇÙ±ê¤ä¾¤Î¡´ï¤Î¾É¾õ¡¢Ìȱ֤Î˽Áö¡¢Ç¥ÉؤؤαƶÁ¤Ê¤É¤òÀìÌç²È¤Ëʹ¤¤¤¿ 2020.02.21¡¡https://nkbp.jp/38s6rVl ¡Ê2·î¤Ë¤³¤ì¤À¤±Ê¬¤«¤Ã¤Æ¤¤¤Æ¡¢Ì¤¤À¤Ë ¡ÉÂǤĤ٤¼ê¤òÂǤ¿¤º¡É7·î¤ËÆÍÆþ¡Ë ¡¡¢ @chikawatanabe 3·î17Æü In Italy, 50-75% cases were asymptomatic when they tested whole city ~3k population ¥¤¥¿¥ê¥¢¤Ç3000¿Í¤Î³¹Á´°÷¤ò¸¡ºº¤·¤¿¤éØí´µ¼Ô¤Î50¡Ý75¡ó¤¬Ìµ¾É¾õ¤Ç¡¢Èà¤é¤ò³ÖÎ¥¤·¤¿¤é´µ¼Ô¿ô¤¬10Æü¤Ç1/10¤Ë¡¡https://bit.ly/2By4L0C
Éð´Á¤Ç¤Ï¤Û¤Ü¤¹¤Ù¤ÆL·¿¤Ç¡¢¤½¤Î¸å¤Î²¤½£¤Ç¤Î³ÈÂç¤ÇS·¿¤¬¼çÂΤȤʤäÆή¹Ô¤·¤¿»ö¤«¤é¡¢L·¿¤«¤éS·¿¤ØÊÑ°Û¤·¤¿¤ÈÅö½é¤Ï¹Í¤¨¤é¤ì¤Æ¤¤¤Þ¤·¤¿¡£ ¤³¤ì¤Ï¶²¤é¤¯Éð´Á¤ËºÇ½é¤Ë¤¿¤É¤êÃ夤¤¿¤Î¤¬L·¿¤À¤Ã¤¿¤À¤±¤Ç¡¢"founder effect"¤Èɽ¸½¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ ¡¦¡¦¡¦³ä°¦¡¦¡¦¡¦ ¤³¤Î¸¶Ãø¤Ï5/20¤Ënature¤Ë·ÇºÜ¤µ¤ì¤Æ¤¤¤Þ¤·¤¿¡£ Viral and host factors related to the clinical outcome of COVID-19 https://go.nature.com/31Ej3HC
¡ú@DNA_PAPA¡¡¡Ê TºÙ˦¡ÄÁ°¤Ë¸«¤¿¤è¤Ê¡Ë ¿··¿¥³¥í¥Ê¤Ë´¶À÷¤·¤¿¥µ¥ë¤Ë1¤«·î¸å¡¢¤â¤¦°ì²ó´¶À÷¤µ¤»¤¿¤È¤³¤í¡¢¤Ï¤Ã¤¤ê¤·¤¿¹³ÂÎÈ¿±þ¤ÈTºÙ˦¤ÎÈ¿±þ¤ò³Îǧ¡¡Ï¯Êó¤Ç¤¹ ¡¡¢ @EricTopol Just out @ScienceMagazine
New and solid evidence that primary infection with #SARSCoV2 preempts reinfection 1 month later, with a strong antibody and T cell response, in the macaques model https://bit.ly/2CZWL8R¡ÊPDF)